234 related articles for article (PubMed ID: 28375831)
1. The effect of anti-TNF treatment on osteoblastogenesis in ankylosing spondylitis: the number of circulating osteoblast-lineage cells in peripheral blood decreased after infliximab therapy in patients with ankylosing spondylitis.
Kwon SR; Jung KH; Lim MJ; Son MJ; Choi BH; Park SG; Park W
Clin Exp Rheumatol; 2017; 35(5):837-843. PubMed ID: 28375831
[TBL] [Abstract][Full Text] [Related]
2. A 1-year prospective study of the effect of infliximab on bone metabolism in inflammatory bowel disease patients.
Veerappan SG; Healy M; Walsh B; O'Morain CA; Daly JS; Ryan BM
Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1335-44. PubMed ID: 27508327
[TBL] [Abstract][Full Text] [Related]
3. Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy.
Kwon SR; Lim MJ; Suh CH; Park SG; Hong YS; Yoon BY; Kim HA; Choi HJ; Park W
Rheumatol Int; 2012 Aug; 32(8):2523-7. PubMed ID: 21833531
[TBL] [Abstract][Full Text] [Related]
4. Osteoprotegerin correlates with disease activity and endothelial activation in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy.
Genre F; López-Mejías R; Miranda-Filloy JA; Ubilla B; Carnero-López B; Palmou-Fontana N; Gómez-Acebo I; Blanco R; Rueda-Gotor J; Pina T; González-Juanatey C; Llorca J; González-Gay MÁ
Clin Exp Rheumatol; 2014; 32(5):640-6. PubMed ID: 25190453
[TBL] [Abstract][Full Text] [Related]
5. Correlation between insulin resistance and serum ghrelin in non-diabetic ankylosing spondylitis patients undergoing anti-TNF-α therapy.
Genre F; López-Mejías R; Miranda-Filloy JA; Carnero-López B; Gómez-Acebo I; Blanco R; Ochoa R; Rueda J; González-Juanatey C; Llorca J; González-Gay MÁ
Clin Exp Rheumatol; 2013; 31(6):913-8. PubMed ID: 23981480
[TBL] [Abstract][Full Text] [Related]
6. Can structural damage be prevented in ankylosing spondylitis?
Sieper J
Curr Opin Rheumatol; 2009 Jul; 21(4):335-9. PubMed ID: 19424070
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy.
Genre F; López-Mejías R; Miranda-Filloy JA; Carnero-López B; Gómez-Acebo I; Blanco R; Ochoa R; Rueda J; González-Juanatey C; Llorca J; González-Gay MA
Clin Exp Rheumatol; 2013; 31(5):749-55. PubMed ID: 23806325
[TBL] [Abstract][Full Text] [Related]
8. Accelerated osteogenic differentiation of human bone-derived cells in ankylosing spondylitis.
Jo S; Kang S; Han J; Choi SH; Park YS; Sung IH; Kim TH
J Bone Miner Metab; 2018 May; 36(3):307-313. PubMed ID: 28589411
[TBL] [Abstract][Full Text] [Related]
9. Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with rheumatoid arthritis and ankylosing spondylitis.
Gengenbacher M; Sebald HJ; Villiger PM; Hofstetter W; Seitz M
Ann Rheum Dis; 2008 May; 67(5):620-4. PubMed ID: 17720725
[TBL] [Abstract][Full Text] [Related]
10. Gelsolin levels are decreased in ankylosing spondylitis patients undergoing anti-TNF-alpha therapy.
Genre F; López-Mejías R; Miranda-Filloy JA; Ubilla B; Carnero-López B; Gómez-Acebo I; Blanco R; Ochoa R; Rueda-Gotor J; González-Juanatey C; Llorca J; González-Gay MA
Clin Exp Rheumatol; 2014; 32(2):218-24. PubMed ID: 24351434
[TBL] [Abstract][Full Text] [Related]
11. Anti-TNF-α therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients.
Genre F; López-Mejías R; Miranda-Filloy JA; Ubilla B; Mijares V; Carnero-López B; Gómez-Acebo I; Dierssen-Sotos T; Remuzgo-Martínez S; Blanco R; Pina T; González-Juanatey C; Llorca J; González-Gay MA
Rheumatol Int; 2015 Dec; 35(12):2069-78. PubMed ID: 26143161
[TBL] [Abstract][Full Text] [Related]
12. TNF-alpha antagonist therapy improves insulin sensitivity in non-diabetic ankylosing spondylitis patients.
Miranda-Filloy JA; Llorca J; Carnero-López B; González-Juanatey C; Blanco R; González-Gay MA
Clin Exp Rheumatol; 2012; 30(6):850-5. PubMed ID: 22765845
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
[TBL] [Abstract][Full Text] [Related]
14. Endothelial dysfunction in ankylosing spondylitis improves after tumor necrosis factor-alpha blockade.
Syngle A; Vohra K; Sharma A; Kaur L
Clin Rheumatol; 2010 Jul; 29(7):763-70. PubMed ID: 20204669
[TBL] [Abstract][Full Text] [Related]
15. Patient-tailored dose reduction of TNF-α blocking agents in ankylosing spondylitis patients with stable low disease activity in daily clinical practice.
Arends S; van der Veer E; Kamps FB; Houtman PM; Bos R; Bootsma H; Brouwer E; Spoorenberg A
Clin Exp Rheumatol; 2015; 33(2):174-80. PubMed ID: 25797228
[TBL] [Abstract][Full Text] [Related]
16. Correlation between two biomarkers of atherosclerosis, osteopontin and angiopoietin-2, in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy.
Genre F; López-Mejías R; Miranda-Filloy JA; Ubilla B; Carnero-López B; Gómez-Acebo I; Blanco R; Ochoa R; Arias-Bajo M; Rueda-Gotor J; Paz-Carreira J; González-Juanatey C; Llorca J; González-Gay MA
Clin Exp Rheumatol; 2014; 32(2):231-6. PubMed ID: 24295386
[TBL] [Abstract][Full Text] [Related]
17. Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis.
Baraliakos X; Haibel H; Listing J; Sieper J; Braun J
Ann Rheum Dis; 2014 Apr; 73(4):710-5. PubMed ID: 23505240
[TBL] [Abstract][Full Text] [Related]
18. Indirect comparison of anti-TNF-α agents for active ankylosing spondylitis: mixed treatment comparison of randomized controlled trials.
Shu T; Chen GH; Rong L; Feng F; Yang B; Chen R; Wang J
Clin Exp Rheumatol; 2013; 31(5):717-22. PubMed ID: 23899710
[TBL] [Abstract][Full Text] [Related]
19. Use of methotrexate in patients with ankylosing spondylitis.
Haibel H; Sieper J
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S128-31. PubMed ID: 21044446
[TBL] [Abstract][Full Text] [Related]
20. Association of ankylosing spondylitis and Crohn's disease successfully treated with infliximab.
Rebelo A; Leite S; Cotter J
BioDrugs; 2010 Dec; 24 Suppl 1():37-9. PubMed ID: 21175236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]